Moreover, Tranilast disrupted the activation of the NF-κB pathway via down-regulation of phosphorylated p65 protein in tumor cells (Fig. 5d) and resulted in a larger degree of DNA damage (Fig. S5a - d). The gene discussed is NFKB1; the disease is neoplasm.